7:38 am BioLineRx completes dose escalation stage of Phase 1/2 study for novel celiac treatment; results expected mid 2014 – HedgeChatter

7:38 am BioLineRx completes dose escalation stage of Phase 1/2 study for novel celiac treatment; results expected mid 2014

11 Mar

7:38 am BioLineRx completes dose escalation stage of Phase 1/2 study for novel celiac treatment; results expected mid 2014

Bystocknews BLRX, stock Comments Off

View todays social media effects on BLRX

View the latest stocks trending across Twitter. Click to view dashboard

See who BioLineRx is hiring next, click here to view

Author